-
effectivehealthcare.ahrq.gov/products/cell-free-dna
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
September 18, 2023 - Key Question Tumor Cell-free DNA for Cancer Screening
1
Key Question Tumor Cell-free DNA for Cancer … this technology for
cancer screening.13
2
A report on the available evidence on tumor cell-free … Draft Key Question
KQ1: What is the (a) efficacy and (b) safety of circulating tumor cell-free DNA screening … Population: Asymptomatic adults at average- or high-risk for cancer
Intervention: Circulating tumor cell-free
-
effectivehealthcare.ahrq.gov/products/form/cell-free-dna
-
effectivehealthcare.ahrq.gov/health-topics/amyloidosis
May 02, 2011 - Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Research Protocol
Archived
May 2, 2011
Serum Free Light Chain Analysis for the … Dyscrasias: Future Research Needs
Systematic Review
Archived
September 19, 2012
Serum Free
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/serum-free-light-chain-analysis-for-the-diagnosis
June 17, 2009 - Serum free light chain analysis for the diagnosis
Serum Free Light Chain Analysis for the Diagnosis
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
May 02, 2011 - Research Protocol Aug. 23, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Serum-Free … NSMM]). 1 In two-thirds of patients with NSMM, a monoclonal protein can be identified by the serum-free … Serum free light chain measurements move to center stage. Clin Chem 2005; 51: 805-7. … Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. … Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay
May 02, 2011 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Topic Initiated
May 02, 2011
Research Protocol
Archived
Serum-Free … Cell Dyscrasias
August 23, 2012
Systematic Review
Archived
Serum Free
-
effectivehealthcare.ahrq.gov/health-topics/immune-system-and-disorders
July 16, 2013 - and Above Living with HIV/AIDS
Research Protocol
Archived
March 3, 2016
Serum-Free … Prognosis of Plasma Cell Dyscrasias
Research Protocol
Archived
May 2, 2011
Serum Free … Dyscrasias: Future Research Needs
Systematic Review
Archived
September 19, 2012
Serum Free
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-key-questions.pdf
January 01, 2018 - survival
Colostomy-free survival
(KQ1, KQ3, KQ5)
Local control
Pathologic complete
response … Fractionation schemes
Outcomes Overall survival
Disease-free survival
Colostomy-free survival
Local … Other dose de-escalation
Outcomes Overall survival
Disease-free survival
Colostomy-free survival … response
Salvage rate
Sphincter preservation
Acute and late toxicity
Overall survival
Disease-free … survival
Colostomy-free survival
Local control
Pathologic complete response
Salvage rate
Sphincter
-
effectivehealthcare.ahrq.gov/health-topics/c%C3%A1ncer-0
December 08, 2017 - Trials Evaluating Treatment for Infertility
Research Report
June 28, 2017
Serum-Free … Prognosis of Plasma Cell Dyscrasias
Research Protocol
Archived
May 2, 2011
Serum Free
-
effectivehealthcare.ahrq.gov/products/survival-quality
April 12, 2013 - Progression-Free Survival: What Does it Mean for Psychological Well-being or Quality of Life? … Topic Initiated
April 12, 2013
Research Report
Progression-Free
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay-future
September 19, 2012 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Initiated
September 19, 2012
Systematic Review
Archived
Serum Free
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
May 02, 2011 - myeloma
Nonsecretory myeloma
Smoldering multiple myeloma
Malignant plasma cells produce free … The normal plasma-cell production of free light chains is from 0.5 to 1.0 g/day.5 The
detection of free … Serum free light chain measurements move to center stage. Clin Chem 2005;
51: 805-7.
5. … Highly sensitive, automated immunoassay
for immunoglobulin free light chains in serum and urine. … Serum reference intervals and diagnostic ranges
for free kappa and free lambda immunoglobulin light
-
effectivehealthcare.ahrq.gov/news/srdr-plus-launch
This new version, called SRDR+ , is a free, powerful, online, collaborative system for extracting and … SRDR+ features major upgrades for:
Researchers as a free platform for extracting, archiving, and sharing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - Serum free light chains for monitoring
multiple myeloma. … Serum free light chains for monitoring
multiple myeloma. … Serum free light chain
measurements move to center stage. … Appraisal of immunoglobulin free light
chain as a marker of response. … of the serum free
light chain response definitions.
-
effectivehealthcare.ahrq.gov/products/survival-quality/research
April 12, 2013 - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? … Structured Abstract
Background
Progression-free survival (PFS), defined as the time from random assignment … The four studies demonstrated better QOL or disease symptoms among patients who remained progression-free … association with OS; and (3) the extent to which improvement in QOL measures associated with progression-free
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or … Ideally, studies would be free
from bias. … Issues
in using progression-free survival when
evaluating oncology products. … The value of
progression-free survival to patients with
advanced-stage cancer. … OR "progression free survival" OR "progression-free survival"
OR "time to progression"
AND
(("Quality
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/search-strategies_research.pdf
June 01, 2012 - Of the 25 peer
reviewers invited to participate, 24 completed the initial free-form round of reviews … , and 15
completed either the PRESS review or a second free-form review as part of our control group … Free-form Review Form
Appendix C. PRESS Review Form
Appendix D. … Objective 3: Compare PRESS instrument to free form evaluations. … Free-Form Review Form
Appendix C. PRESS Review Form
Appendix D.
-
effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
August 16, 2010 - on Chronic Disease Outcomes and Risks
Systematic Review
June 21, 2018
Serum-Free … Prognosis of Plasma Cell Dyscrasias
Research Protocol
Archived
May 2, 2011
Serum Free … Dyscrasias: Future Research Needs
Systematic Review
Archived
September 19, 2012
Serum Free
-
effectivehealthcare.ahrq.gov/products/search-strategies/research
June 07, 2012 - Specific Aims :
Evaluate whether the PRESS instrument or no-instrument (‘free-form’ evaluations) is … Each TEPR was assigned to either the control group who only wrote “free-form” reviews or to the group … who initially wrote a “free-form” review, then trained using the PRESS Instrument, and finally completed … Of the 25 peer reviewers invited to participate, 24 completed the initial free-form round of reviews, … and 15 completed either the PRESS review or a second free-form review as part of our control group.